生物技术公司Kodiak Sciences Inc. (KOD) 今日盘前股价大幅上涨5.56%，引起了市场关注。
消息面上，华尔街分析师发布了针对该公司的积极研究报告。其中，杰富瑞（Jefferies）将Kodiak Sciences的目标股价从39美元大幅上调至56美元。与此同时，H.C. Wainwright也将其目标价从38美元上调至58美元。分析师上调目标价通常被视为对公司未来前景的乐观信号，这直接提振了市场信心，推动了股价在盘前交易时段走强。
这些评级调整发生在周五的常规分析师研究更新中，反映出机构对Kodiak Sciences在其专业领域内发展潜力的重新评估。此类积极的分析师行动往往是短期内影响股价波动的重要因素。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.